Mondelez International just reported Q2 results and the Street liked what it heard — shares jumped nearly 3% on Tuesday to close at $62.48, extending a 4.4% weekly gain that puts the snacks giant comfortably ahead of most packaged-food peers.
The catalyst is fresh analyst activity. TD Cowen raised its price target to $70 from $67 today, maintaining its Buy rating — a move that validates the bullish read on the print. That puts the consensus mean target at $68.86, implying roughly 10% upside from current levels. The broader analyst community has been constructive for months. After a cluster of target raises following the Q1 print in late April — from JP Morgan, Evercore, Barclays, and BofA among others — the direction of travel is clearly upward, even if UBS remains sidelined at Neutral with a $64 target. Bulls point to Oreo and Cadbury brand strength, emerging-market distribution gains, and 10-11% EPS growth potential. Bears flag cocoa deflation, rising energy costs, and private-label encroachment squeezing gross margins. The P/E multiple has edged up to 19.3x, with EV/EBITDA near 14.2x — neither stretched nor cheap for a global consumer staples name, but both drifting modestly higher alongside the stock's recovery.
Positioning in the lending market and options tells a quiet story — this is not a name under meaningful short pressure. Short interest at 2.6% of the free float is low by any measure, and the week's 5.6% rise in shares short is modest in absolute terms given where it starts. Borrowing costs remain negligible at 0.37%, and availability in the lending pool is extraordinarily loose — currently running at nearly 70 times the shares already borrowed, well above even the 52-week low availability reading. There is no squeeze dynamic here. The options market is mildly more cautious than usual: the put/call ratio at 1.13 sits about one standard deviation above its 20-day average of 1.03, a step up from the sub-1.0 readings that dominated late June and early July. That modest shift toward protective puts is consistent with investors locking in gains after the post-earnings pop, rather than expressing any deep bearish conviction.
The ORTEX short score of 35.2 — ranking in the 46th percentile — reinforces the neutral-to-friendly picture for longs. Factor scores are mixed: dividend ranks in the 55th percentile, days-to-cover similarly at 55, but EV/EBIT scores just 17th percentile, a persistent valuation drag the stock-score notes have flagged for months. Among close peers, KHC posted an even stronger week at +5.9%, while POST led the group at +6.7%. CPB and CAG both gained but more modestly, suggesting the sector broadly caught a bid rather than MDLZ outperforming on idiosyncratic strength alone.
Institutional ownership is broadly stable, with Capital Research at 9.4%, BlackRock adding around 5 million shares to reach 8.3%, and T. Rowe Price adding nearly 6.6 million shares to hold 3.4% — the larger active managers incrementally building rather than trimming. Insider activity is thin and low-significance: the Chief Accounting Officer sold token amounts in late April and early May, while earlier transactions in February were largely award-related sales by the CEO and senior vice presidents at similar price levels to today's close. Nothing in the insider data disrupts the broadly constructive read.
The next earnings date is October 27. Between now and then, the conversation centres less on whether Mondelez can grow and more on whether the cocoa cost tailwind and emerging-market volume trends hold long enough to justify a multiple that has been drifting higher through the summer.
See the live data behind this article on ORTEX.
Open MDLZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
